Onconetix, Inc. (ONCO): Nasdaq/NYSE listing notice — Onconetix receives additional Nasdaq delisting notice for late 10-K; hearing set for May 27

Onconetix, Inc.

Received April 24, 2025 notice for failing to file FY2024 10-K, violating Listing Rule 5250(c)(1).
Already faces delisting for bid price below $0.10; hearing scheduled May 27, 2025.
Must request stay by May 1, 2025 to delay suspension pending Panel decision.
Company intends to file 10-K promptly but no assurance of panel relief.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Onconetix, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

April 24, 2025, Onconetix, Inc. (the “ Company ”) received a deficiency notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company was not in compliance with Nasdaq’s continued listing standards (the “ Listing Rules ”) as set forth in Listing Rule 5250(c)(1) given the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “ 10-K ”), and that this matter serves as an additional basis for delisting the Company’s securities from Nasdaq. As previously reported in the Current Report on Form 8-K filed with the Secu

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-037765

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.